Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
Teplizumab治疗可能改善1型糖尿病新发病期后患者的C肽反应：一项随机对照试验
期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-012-2753-4
Herold, K C; Gitelman, S E; Willi, S M; Gottlieb, P A; Waldron-Lynch, F; Devine, L; Sherr, J; Rosenthal, S M; Adi, S; Jalaludin, M Y; Michels, A W; Dziura, J; Bluestone, J A
